Federated Hermes’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.5M | Sell |
344,304
-3,062
| -0.9% | -$156K | 0.03% | 454 |
|
|
2025
Q1 | $15.6M | Buy |
347,366
+343,725
| +9,440% | +$15.5M | 0.03% | 455 |
|
|
2024
Q4 | $151K | Sell |
3,641
-359
| -9% | -$14.8K | ﹤0.01% | 1526 |
|
|
2024
Q3 | $156K | Sell |
4,000
-1,400
| -26% | -$54.6K | ﹤0.01% | 1519 |
|
|
2024
Q2 | $185K | Sell |
5,400
-3,600
| -40% | -$123K | ﹤0.01% | 1492 |
|
|
2024
Q1 | $226K | Buy |
9,000
+4,000
| +80% | +$100K | ﹤0.01% | 1471 |
|
|
2023
Q4 | $148K | Sell |
5,000
-15,544
| -76% | -$459K | ﹤0.01% | 1550 |
|
|
2023
Q3 | $649K | Buy |
20,544
+8,544
| +71% | +$270K | ﹤0.01% | 1261 |
|
|
2023
Q2 | $310K | Hold |
12,000
| – | – | ﹤0.01% | 1491 |
|
|
2023
Q1 | $288K | Buy |
12,000
+2,000
| +20% | +$48K | ﹤0.01% | 1531 |
|
|
2022
Q4 | $195K | Buy |
10,000
+9,985
| +66,567% | +$195K | ﹤0.01% | 1560 |
|
|
2022
Q3 | $1K | Sell |
15
-15
| -50% | -$1K | ﹤0.01% | 2060 |
|
|
2022
Q2 | $1K | Sell |
30
-19,955
| -100% | -$665K | ﹤0.01% | 2058 |
|
|
2022
Q1 | $440K | Buy |
+19,985
| New | +$440K | ﹤0.01% | 1481 |
|
|
2019
Q4 | – | Sell |
-29,232
| Closed | -$294K | – | 2266 |
|
|
2019
Q3 | $294K | Buy |
+29,232
| New | +$294K | ﹤0.01% | 1523 |
|